Security key
552641102
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (MAIA)
CUSIP: 552641102
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 34,135
- Total 13F value
- $49,154
- Share change
- 0
- SEC-reported price per share
- $1.44
- Number of holders
- 1
- Shares outstanding
- 60,521,183
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
MAIA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
MAIA Biotechnology, Inc. SEC filings
MAIA Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 552641102
Recent filing periods:
Ownership snapshot
Top reported holders of MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FGMK Business Holdings, LLC
Disclosed value leader
FGMK Business Holdings, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
13D/G row: FGMK Business Holdings, LLC
Showing 1-6 of 15 holder rows.
Quick read
FGMK Business Holdings, LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FGMK Business Holdings, LLC's linked filing trail.
Comparable ownership
Top 5
FGMK Business Holdings, LLC
10%
Vlad Vitoc
9.7%
Solas Capital Management, LLC
7.1%
Sergei M. Gryaznov
4.1%
Alyeska Investment Group, L.P.
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FGMK Business Holdings, LLC |
13D/G
|
10%
|
$6,068,078
2,889,561 shares
|
$0 | 14 Sep 2024 |
| Vlad Vitoc |
13D/G
3/4/5
Chief Executive Officer, Director, 10%+ Owner
|
9.7%
|
$4,307,914
3,846,352 shares
|
$0 | 21 Nov 2025 |
| Solas Capital Management, LLC |
13F
13D/G
Company
|
7.1%
from 13D/G
|
$6,015,806
4,297,004 shares
|
— | 31 Mar 2026 |
| Sergei M. Gryaznov |
13D/G
3/4/5
Chief Scientific Officer
|
4.1%
|
$2,394,242
1,140,115 shares
|
$0 | 31 Dec 2023 |
| Alyeska Investment Group, L.P. |
13F
Company
|
4.1%
|
$3,500,000
2,500,000 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
3.4%
|
$2,903,663
2,074,045 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
34,135
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
32
Q2 2026 holders
1
Holder diff
-31
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend